Home > Publications database > Endosialin-Expressing Pericytes Promote Metastatic Dissemination. > print |
001 | 130729 | ||
005 | 20240228143457.0 | ||
024 | 7 | _ | |a 10.1158/0008-5472.CAN-16-0932 |2 doi |
024 | 7 | _ | |a pmid:27635044 |2 pmid |
024 | 7 | _ | |a 0008-5472 |2 ISSN |
024 | 7 | _ | |a 0099-7013 |2 ISSN |
024 | 7 | _ | |a 0099-7374 |2 ISSN |
024 | 7 | _ | |a 1538-7445 |2 ISSN |
024 | 7 | _ | |a altmetric:12016730 |2 altmetric |
037 | _ | _ | |a DKFZ-2017-05807 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Viski, Carmen |b 0 |
245 | _ | _ | |a Endosialin-Expressing Pericytes Promote Metastatic Dissemination. |
260 | _ | _ | |a Philadelphia, Pa. |c 2016 |b AACR |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1521189872_1713 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Metastasis is a multistep process that is critically dependent on the interaction of metastasizing tumor cells with cells in the local microenvironment. Within this tumor stroma, vessel-associated pericytes and myofibroblasts share a number of traits, including the upregulated expression of the transmembrane receptor endosialin (CD248). Comparative experiments in wild-type and endosialin-deficient mice revealed that stromal endosialin does not affect primary tumor growth but strongly promotes spontaneous metastasis. Mechanistically, endosialin-expressing pericytes in the primary tumor facilitate distant site metastasis by promoting tumor cell intravasation in a cell contact-dependent manner, resulting in elevated numbers of circulating tumor cells. Corresponding to these preclinical experiments, in independent cohorts of primary human breast cancers, upregulated endosialin expression significantly correlates with increased metastasis and poorer patient survival. Together, the data demonstrate a critical role for endosialin-expressing primary tumor pericytes in mediating metastatic dissemination and identify endosialin as a promising therapeutic target in breast cancer. Cancer Res; 76(18); 5313-25. ©2016 AACR. |
536 | _ | _ | |a 311 - Signalling pathways, cell and tumor biology (POF3-311) |0 G:(DE-HGF)POF3-311 |c POF3-311 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
650 | _ | 7 | |a Antigens, CD |2 NLM Chemicals |
650 | _ | 7 | |a Antigens, Neoplasm |2 NLM Chemicals |
650 | _ | 7 | |a CD248 protein, human |2 NLM Chemicals |
650 | _ | 7 | |a Neoplasm Proteins |2 NLM Chemicals |
650 | _ | 7 | |a tumor endothelial marker 1, mouse |2 NLM Chemicals |
700 | 1 | _ | |a König, Courtney |0 P:(DE-He78)5ef958977fa3c0658679b496419ce762 |b 1 |e First author |u dkfz |
700 | 1 | _ | |a Kijewska, Magdalena |b 2 |
700 | 1 | _ | |a Mogler, Carolin |0 P:(DE-He78)18e5b355e4a312d2065b1ae2a9d47654 |b 3 |u dkfz |
700 | 1 | _ | |a Isacke, Clare M |b 4 |
700 | 1 | _ | |a Augustin, Hellmut |0 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b |b 5 |e Last author |u dkfz |
773 | _ | _ | |a 10.1158/0008-5472.CAN-16-0932 |g Vol. 76, no. 18, p. 5313 - 5325 |0 PERI:(DE-600)2036785-5 |n 18 |p 5313 - 5325 |t Cancer research |v 76 |y 2016 |x 1538-7445 |
909 | C | O | |o oai:inrepo02.dkfz.de:130729 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)5ef958977fa3c0658679b496419ce762 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)18e5b355e4a312d2065b1ae2a9d47654 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-311 |2 G:(DE-HGF)POF3-300 |v Signalling pathways, cell and tumor biology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2016 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER RES : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CANCER RES : 2015 |
920 | 1 | _ | |0 I:(DE-He78)A190-20160331 |k A190 |l Vaskuläre Onkologie und Metastasierung |x 0 |
920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)A190-20160331 |
980 | _ | _ | |a I:(DE-He78)L101-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|